Occam Biosciences Limited
Research and experimental development on biotechnology · Dundee
ActiveUnited KingdomIncorporated 2021Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-08-31
IXBRL · 123 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2025-08-31
IXBRL · 123 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-09-01 to 2025-08-31
- Extraction status
- complete
- Numeric facts
- 64
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2510_SC707668_20250831
- Source archive
- Accounts_Monthly_Data-October2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-08-31
IXBRL · 148 source facts · 24 selected values
Validation findingsXBRL valid
Accounts to 2024-08-31
IXBRL · 148 source facts · 24 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-09-01 to 2024-08-31
- Extraction status
- complete
- Numeric facts
- 86
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2503_SC707668_20240831
- Source archive
- Accounts_Monthly_Data-March2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-08-31
IXBRL · 128 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2023-08-31
IXBRL · 128 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2022-09-01 to 2023-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 74
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2166_SC707668_20230831
- Source archive
- Accounts_Monthly_Data-May2024.zip
Accounts to 2022-08-31
IXBRL · 99 source facts · 9 selected values
Not assessedlegacy record
Accounts to 2022-08-31
IXBRL · 99 source facts · 9 selected values
Not assessed
legacy record
- Reporting period
- 2021-08-25 to 2022-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 47
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0013_SC707668_20220831
- Source archive
- Accounts_Monthly_Data-May2023.zip
Registered details
SC707668- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2021-08-25
- Jurisdiction
- —
- Registered office
- PROSPECT II, PROSPECT BUSINESS CENTRE, DUNDEE, DD2 1TY
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsCultLeather: Scaled Production of Lab Grown LeatherLeadInnovate UK · Collaborative R&D · 2025-06-01 – 2026-05-31 · with 2 other participants£239,017awarded
CultLeather: Scaled Production of Lab Grown LeatherLead
Innovate UK · Collaborative R&D · 2025-06-01 – 2026-05-31 · with 2 other participants
£239,017
awarded
Occam Biosciences Limitedlead£239,017
Discovery platform for novel thermostable recombinant growth factorsLeadLiveInnovate UK · Collaborative R&D · 2025-04-01 – 2026-09-30 · with 1 other participant£218,306awarded
Discovery platform for novel thermostable recombinant growth factorsLeadLive
Innovate UK · Collaborative R&D · 2025-04-01 – 2026-09-30 · with 1 other participant
£218,306
awarded
Occam Biosciences Limitedlead£218,306
University of Edinburgh£123,407
Towards massive scale-up of low-cost growth factor production for meat cultivationLead
Innovate UK · Grant for R&D · 2022-11-01 – 2023-04-30
£49,622
awarded